Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-036180
Filing Date
2025-04-28
Accepted
2025-04-28 17:12:38
Documents
16
Period of Report
2025-03-25
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0239462-8ka1_rafael.htm   iXBRL 8-K/A 36416
2 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF CYCLO THERAPEUTICS, INC. AS OF AND ea023946201ex99-1_rafael.htm EX-99.1 364213
3 UNAUDITED PRO FORMA CONDENSED COMBINED CONSOLIDATED BALANCE SHEET AS OF JANUARY ea023946201ex99-2_rafael.htm EX-99.2 678796
  Complete submission text file 0001213900-25-036180.txt   1404677

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250325.xsd EX-101.SCH 3777
5 XBRL DEFINITION FILE rfl-20250325_def.xml EX-101.DEF 26617
6 XBRL LABEL FILE rfl-20250325_lab.xml EX-101.LAB 36669
7 XBRL PRESENTATION FILE rfl-20250325_pre.xml EX-101.PRE 25241
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0239462-8ka1_rafael_htm.xml XML 6256
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 001-38411 | Film No.: 25881525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)